Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Immix Biopharma, Inc. (IMMX) had Free Cash Flow of $-34.05M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-13.93M |
|
-- |
|
-- |
|
$15.95M |
|
$-15.95M |
|
$2.02M |
|
$-13.93M |
|
$-13.93M |
|
$-13.93M |
|
$-13.93M |
|
$-13.93M |
|
$-13.93M |
|
$-15.95M |
|
$-15.83M |
|
74.09M |
|
74.09M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$338.08M |
|
$2.41M |
|
$7.87M |
|
$345.95M |
|
$10.03M |
|
-- |
|
$0.87M |
|
$10.89M |
|
$335.06M |
|
$335.06M |
|
$335.06M |
|
83.81M |
|
| Cash Flow Statement Financials | |
$-33.87M |
|
$-14.16M |
|
$274.41M |
|
$93.93M |
|
$320.32M |
|
$226.39M |
|
$2.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
33.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-34.05M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.16% |
|
-4.16% |
|
-4.03% |
|
-4.16% |
|
$4.00 |
|
$-0.46 |
|
$-0.46 |
|